Mr. Nemiroff has been an analyst at MAK Capital since 2016 and has worked in investments since 2008. Previously, he held business development and corporate development roles at MRU Holdings and Capital One Financial.
Eric Keller is founder and CEO of Redux Therapeutics, co-founder and head of strategy at C2Sense, and executive vice president of SGH2 Energy Global. He has nearly 30 years of experience at life sciences companies.
Karin Potoka joined Noveome as chief medical officer in 2023. She earned a medical degree from the University of Pittsburgh School of Medicine and completed her residency and fellowship at UPMC Children’s Hospital of Pittsburgh.
Dr. Brown joined Noveome in 2012 after more than 35 years in pharmaceutical companies. At Baxter Healthcare Corporation, he was vice president of research and corporate head of drug delivery; he has developed pharmaceutical formulations and product portfolios and published more than 100 papers.
